VRXA · Veraxa Biotech Holding AG
$1.85
-0.02 (-1.07%)
At close · Aug 17
Market Cap
$271.62M
Shares
145.25M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-09 | Buergermeister Torsten Georg Friedrich |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-09 | Antz Christoph Rudiger |
Director, Chief Executive Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-09 | Gruninger Marc |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-09 | Schwer Heinz |
Chief Business Officer |
Other↑
|
No Securities Owned
|
0 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–4 of 4 transactions
Key facts
CIK
2079109
CUSIP
H9130A103
13F (30d)
30 filings
30 filers
Visit website
Investor relations